XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.540
-0.035 (-1.36%)
Apr 28, 2026, 4:00 PM EDT - Market closed

XBiotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-45.54-38.53-24.56-32.9-17.41
Upgrade
Depreciation & Amortization
1.691.751.742.612.65
Upgrade
Stock-Based Compensation
3.621.753.265.064.46
Upgrade
Other Operating Activities
-3.335.53-1.892.8-
Upgrade
Change in Accounts Receivable
----4.11
Upgrade
Change in Accounts Payable
-0.69-0.360.090.36-0.51
Upgrade
Change in Income Taxes
0.31-0.110.68.71-2.17
Upgrade
Change in Other Net Operating Assets
4.02-0.992.09-0.6576.91
Upgrade
Operating Cash Flow
-39.92-30.96-18.73-14.8269.45
Upgrade
Capital Expenditures
-0.29-1.3-0.36-0.59-3.53
Upgrade
Investment in Securities
--61.86-63.31-
Upgrade
Investing Cash Flow
-0.29-1.361.5-63.89-3.53
Upgrade
Short-Term Debt Issued
-10.25---
Upgrade
Total Debt Issued
-10.25---
Upgrade
Short-Term Debt Repaid
-10.25----
Upgrade
Total Debt Repaid
-10.25----
Upgrade
Net Debt Issued (Repaid)
-10.2510.25---
Upgrade
Issuance of Common Stock
-0.20.01-8
Upgrade
Common Dividends Paid
-----75
Upgrade
Other Financing Activities
---0.01--
Upgrade
Financing Cash Flow
-10.2510.45-0.01--67.01
Upgrade
Foreign Exchange Rate Adjustments
3.33-5.53-0.05-0.960.71
Upgrade
Net Cash Flow
-47.13-27.3542.72-79.68-0.38
Upgrade
Free Cash Flow
-40.21-32.27-19.09-15.4165.92
Upgrade
Free Cash Flow Margin
----384.26%358.38%
Upgrade
Free Cash Flow Per Share
-1.32-1.06-0.63-0.512.19
Upgrade
Cash Interest Paid
0.490.4---
Upgrade
Cash Income Tax Paid
-0.080.090.14--
Upgrade
Levered Free Cash Flow
-26.28-26.29-16.1-6.3366
Upgrade
Unlevered Free Cash Flow
-26.22-25.79-16.1-6.3366
Upgrade
Change in Working Capital
3.64-1.462.727.679.75
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.